Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

GREY:CLAZF - Post Discussion

Claritas Pharmaceuticals Inc > More good news for SaNOtize more good news for us....
View:
Post by Dude51 on Apr 16, 2021 11:58pm

More good news for SaNOtize more good news for us....

Wow, CLA$ is going, 10 cents Monday or next Monday. Good luck Shorties...lol


https://timesofindia.indiatimes.com/world/uk/anti-covid-nasal-spray-in-approval-queue-could-be-game-changer-for-india-scientist/articleshow/82102517.cms


GLTA
Comment by Scotty on Apr 17, 2021 2:43am
This is the first company I've ever heard of where investors think good news for the competition benefits them.
Comment by Thanks1 on Apr 17, 2021 5:47am
It's the localized verses systemic treatment options I'm guessing, we will see.
Comment by 8CornerPocket on Apr 17, 2021 9:08am
Yeah, I don't see how it can be a bad thing from a shareholder perspective to believe sanotize's current media success is bad. Claritas is claiming to have a better product and sanotize is private so if you're looking to invest in this type product right now... we're it. So lets ride sanotize media coat tails until R-107 is ready and release a far more superior product then. What ...more  
Comment by Scotty on Apr 17, 2021 9:59am
Financing.
Comment by whisky11 on Apr 17, 2021 10:21am
Scotty] Financing. whisky11: how financing would look like if Claritas bought  Salzman Group? Now the situation is different, Claritas buy R-107 programs I would say that it will be something similar mix of government funds and PP. The huge number of shares which Claritas would have to issue was to buy all Salzman Group. R-107 is a liquid prodrug of nitric oxide. Based on the fact ...more  
Comment by 8CornerPocket on Apr 17, 2021 10:43am
Financing... ok so as per some of the replies to your post already, the other literature that's been shared here about financing in the past and the poking around I've done myself about their financials, I don't see how financing is an issue right now either? I would suggest every company has to deal with financial hurdles as they navigate through the various stages of research ...more  
Comment by Dude51 on Apr 17, 2021 9:58am
RE:More good news for SaNOtize more good news for us.... This is the first company I've ever heard of where investors think good news for the competition benefits them. That's because you think this is a shell company to begin with Scotty.  Let me explain loser, you see SaNOtize has one product to our many. That one product is something we can produce to compete with SaNOtize and ...more  
Comment by Bigginvestor on Apr 17, 2021 10:22am
well said that is true claritas has the funding .. ppl need to read in all the NR They have the funding this is why we will go far can't wait to pop the bubbly bubbly!!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities